GELS

Gelteq Limited Ordinary Shares (GELS)

Stock · NASDAQ · Health Care

$0.446as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 2, 2026

GELS Featured in Pre-Market Healthcare Movers List. Gelteq Limited (GELS) was included in a Benzinga list of healthcare stocks moving in Friday's pre-market session. The stock is currently trading near its support level of $0.69, within a 52-week range of $0.39 to $2.01. This inclusion highlights recent trading activity in the sector.

Active signals

Resistance level
$0.551588
Industry
Biotechnology: Pharmaceutical Preparations

What GELS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike11-17.8%18%
Bollinger Band Breakdown4-9.2%50%
Bollinger Band Breakout4-26.1%25%
Any 20-session window (baseline)-6.5%37%

Computed by MarketWall from daily closing prices since August 18, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About GELS

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
7

Fundamentals

1-day range
$0.43$0.4495
Market cap
$6.15M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
$-1.06
Dividend yield
—
Beta
1.16
Avg. volume
2.86M
52-week range
$0.387$2.01

Gelteq Limited Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • GELS
    Gelteq Limited Ordinary Shares
    $0.446
    ▲ 3.48%
    Market cap $6.15MP/E —
    $0.387$2.01
  • APVO
    Aptevo Therapeutics Inc. Common Stock
    $1.62
    ▼ 4.71%
    Market cap $6.18MP/E 0.00
    $1.37$30.06
  • HCWB
    HCW Biologics Inc. Common Stock
    $1.24
    ▲ 0.81%
    Market cap $6.19MP/E —
    $1.14$27.3
  • PULM
    Pulmatrix Inc. Common Stock
    $1.36
    ▼ 3.55%
    Market cap $6.06MP/E —
    $1.16$5.24
  • ACXP
    Acurx Pharmaceuticals Inc. Common Stock
    $1.1
    ▼ 5.98%
    Market cap $6.27MP/E —
    $1.15$7.87
  • ENVB
    Enveric Biosciences Inc. Common Stock
    $1.38
    ▼ 0.72%
    Market cap $6.28MP/E —
    $1.17$13.25
  • SILO
    Silo Pharma Inc. Common Stock
    $1.18
    ▼ 1.67%
    Market cap $5.85MP/E —
    $1.3$10.44

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.